Generic Flonase and GSK vs Par and Roxane Labs
Being a Flonase user for a couple of years now and having recently changed insurance, I’ve been keeping my eyes open with regard to the generic Flonase being brought to the market by Par Laboratories. Flonase is one of those blockbuster drugs (annual sales last year of $1.2 billion) and keeping the generic off the market for even one day would mean $3.29 million in sales, so it’s no wonder GlaxoSmithKline (GSK) tried to prevent it.
Parr and Roxane both started to ship the product on Feb 23 one day after the FDA ruled for their ANDA, but stopped when the US District Court in Maryland issued a temporary restraining order. They resumed shipments on March 7 after the court ruled against GSK and it looks like GSK will not challenge this further.
Mongabay.com has a good timeline of news articles regarding Flonase (fluticasone propionate).
Technorati Tags: Flonase
Related Posts:
Bookmark it with:
| 
del.icio.us
| 
Digg it
| 
Furl
| 
Simpy
| 
Spurl
| 
My Yahoo!
|
